Search Results

There are 12050 results for: content related to: Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

  1. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  2. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1633–1653, L. Puig, A. López, E. Vilarrasa and I. García

    Version of Record online : 19 AUG 2013, DOI: 10.1111/jdv.12238

  3. Sequential treatment with biologics: switching from efalizumab to etanercept in 35 patients with high-need psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue 12, December 2010, Pages: 1413–1420, C Antoniou, C Dessinioti, T Vergou, AJ Stratigos, G Avgerinou, M Kostaki and A Katsambas

    Version of Record online : 9 NOV 2010, DOI: 10.1111/j.1468-3083.2010.03661.x

  4. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus

    Journal of the European Academy of Dermatology and Venereology

    Volume 20, Issue 8, September 2006, Pages: 988–998, W-H Boehncke, RA Brasie, J Barker, S Chimenti, E Daudén, M De Rie, L Dubertret, A Giannetti, A Katsambas, K Kragballe, JM Naeyaert, J-P Ortonne, J Peyrí, JC Prinz, J-H Saurat, R Strohal, P Van De Kerkhof and W Sterry

    Version of Record online : 4 AUG 2006, DOI: 10.1111/j.1468-3083.2006.01707.x

  5. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  6. Unaltered Etanercept Pharmacokinetics With Concurrent Methotrexate in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 44, Issue 11, November 2004, Pages: 1235–1243, Dr Honghui Zhou, Dr Philip R. Mayer, Dr Joseph Wajdula and Dr Saeed Fatenejad

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268049

  7. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

    British Journal of Dermatology

    Volume 159, Issue 5, November 2008, Pages: 1177–1185, P.C.M. Van De Kerkhof, S. Segaert, M. Lahfa, T.A. Luger, Z. Karolyi, A. Kaszuba, G. Leigheb, F.M. Camacho, D. Forsea, C. Zang, M.P. Boussuge, L. Paolozzi and J. Wajdula

    Version of Record online : 31 JUL 2008, DOI: 10.1111/j.1365-2133.2008.08771.x

  8. You have full text access to this OnlineOpen article
    A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 649–657, A.B. Gottlieb, R.G. Langley, B.E. Strober, K.A. Papp, P. Klekotka, K. Creamer, E.H.Z. Thompson, M. Hooper and G. Kricorian

    Version of Record online : 27 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11015.x

  9. You have free access to this content
    Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

    Intervention Review

    The Cochrane Library

    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven and Bart(holomeus) JF van den Bemt

    Published Online : 29 SEP 2014, DOI: 10.1002/14651858.CD010455.pub2

  10. Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept

    British Journal of Dermatology

    Volume 172, Issue 1, January 2015, Pages: 230–238, C.E.M. Griffiths, W. Sterry, F. Brock, M. Dilleen, D. Stefanidis, J.M. Germain and L. Mallbris

    Version of Record online : 13 NOV 2014, DOI: 10.1111/bjd.13139

  11. Biologic Response Modifiers and Pediatric Psoriasis

    Pediatric Dermatology

    Volume 32, Issue 3, May/June 2015, Pages: 303–320, Fernanda Bellodi Schmidt and Kara N. Shah

    Version of Record online : 26 FEB 2015, DOI: 10.1111/pde.12547

  12. Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin

    The Journal of Clinical Pharmacology

    Volume 44, Issue 5, May 2004, Pages: 543–550, Dr Honghui Zhou, Dr Alain Patat, Ms Virginia Parks, Ms Mary Buckwalter, Dr Deborah Metzger and Dr Joan Korth-Bradley

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004264164

  13. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2

  14. You have free access to this content
    Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 50, Issue 2, February 2004, Pages: 353–363, Edward C. Keystone, Michael H. Schiff, Joel M. Kremer, Shelly Kafka, Michael Lovy, Todd DeVries and Daniel J. Burge

    Version of Record online : 5 FEB 2004, DOI: 10.1002/art.20019

  15. You have full text access to this OnlineOpen article
    A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 2, February 2015, Pages: 361–366, K.A. Papp, K. Barber, R. Bissonnette, M. Bourcier, C.W. Lynde, Y. Poulin, J. Shelton, J. Toole, A. Vieira and M. Poulin-Costello

    Version of Record online : 1 JUL 2014, DOI: 10.1111/jdv.12555

  16. Clinical Pharmacokinetics of Etanercept: A Fully Humanized Soluble Recombinant Tumor Necrosis Factor Receptor Fusion Protein

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 490–497, Honghui Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004273321

  17. The risk of deep fungal infections during biologic therapy for psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 10, October 2014, Pages: 1277–1285, N. Jourabchi, L. Adelzadeh and J.J. Wu

    Version of Record online : 10 JUN 2014, DOI: 10.1111/jdv.12508

    Corrected by:

    Erratum: Erratum

    Vol. 29, Issue 1, 193–194, Version of Record online: 22 DEC 2014

  18. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 838–846, P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. De Jong

    Version of Record online : 22 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09950.x

  19. Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 11, November 2012, Pages: 1331–1344, T.C. Lucka, D. Pathirana, A. Sammain, F. Bachmann, S. Rosumeck, R. Erdmann, J. Schmitt, H. Orawa, B. Rzany and A. Nast

    Version of Record online : 9 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04492.x

  20. You have free access to this content
    Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

    Arthritis & Rheumatism

    Volume 60, Issue 9, September 2009, Pages: 2794–2804, E. H. Giannini, N. T. Ilowite, D. J. Lovell, C. A. Wallace, C. E. Rabinovich, A. Reiff, G. Higgins, B. Gottlieb, N. G. Singer, Pediatric Rheumatology Collaborative Study Group, Y. Chon, S.-L. Lin and S. W. Baumgartner

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24777